Michael D Blaszyk insider trades
Open-market stock purchases and sales by Michael D Blaszyk, Director at ImmunityBio, Inc, from SEC Form 4 filings since May 13, 2016.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +220%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | IBRX ImmunityBio, Inc | Bought (not open market) | — |